<DOC>
	<DOCNO>NCT02122328</DOCNO>
	<brief_summary>The investigator hypothesize treatment twin-twin transfusion syndrome ( TTTS ) use sequential laser photocoagulation communicate vessel ( SQLPCV ) predominant method , selective laser photocoagulation communicate vessel ( SLPCV ) , may provide vascular stability donor fetus . The primary objective evaluate perinatal outcome , specifically , donor intrauterine survival TTTS manage SQLPCV vs. SLPCV prospective , randomized trial .</brief_summary>
	<brief_title>Sequential vs. Standard Laser Treatment Twin-twin Transfusion Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fetofetal Transfusion</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Gestational age : 16 week , 0 day 26 week , 0 day . Confirmed TTTS patient , definition meet follow sonographic criterion : Single placenta . Polyhydramnios : maximum vertical pocket ≥ 8 cm recipient twin , prior amniodrainage . Oligohydramnios : maximum vertical pocket ≤ 2 cm donor twin , prior amniodrainage . Thin divide membrane ( absence twin peak sign ) absence divide membrane ( monoamniotic ) . Same gender , visible . Quintero Stages 14 . Patients choose laser therapy undergone prior therapeutic amniocentesis may include . Patients anterior placenta may include . Triplet gestation two three fetus share placenta may include . Patients must able give write informed consent . Patients unable unwilling participate study follow . Patients unable give write informed consent . Presence major congenital anomaly may warrant surgery . Known unbalance chromosomal complement . Prior intentional septostomy ( purposely make hole divide membrane ) . Ruptured membrane . Chorioamnionitis . Abnormal intracranial ultrasound finding either fetus include , limited : intraventricular hemorrhage , porencephalic cyst , hydrocephalus , DandyWalker syndrome , holoprosencephaly agenesis corpus callosum . Isolated ventriculomegaly ( atrium 1019 mm ) may may use exclusion criterion . Placental abruption . Active labor . Patient unwilling receive blood product . Recipient twin middle cerebral artery peak systolic velocity &gt; 1.5 multiple median ( indicative fetal anemia ) . Any patient deem inappropriate study principal investigator .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Twin twin transfusion syndrome</keyword>
	<keyword>Sequential laser photocoagulation communicating vessel</keyword>
</DOC>